Who we are
CNX Therapeutics is a speciality pharmaceutical company committed to improving the lives of patients by providing access to essential medicines
We commercialise and distribute a portfolio of pharmaceuticals for neurological, psychiatric and hospital emergencies in 40 countries worldwide, both directly and through strategic partnerships.
Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe. CNX is an attractive partner for companies who are looking for a pan-European partner for Central Nervous System (CNS) and niche hospital products, which is committed to the highest standards of ethics and sustainability.
CNX aims to have a pioneering and industry-leading approach to Environment, Social and Governance (ESG) goals, which forms a key element of our organisation’s mission and objectives.